搜索





搜索





市场行情
/
股票
/
tsha
/

Taysha Gene Therapies Inc

TSHA

添加自选

5.860USD

-0.015-0.26%

收盘 07-31 16:00（美东）报价延迟15分钟

1.87B总市值

亏损市盈率 TTM

Taysha Gene Therapies Inc

5.860

-0.015-0.26%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

TSHA 利润表

您可以在这里找到Taysha Gene Therapies Inc的年度或季度收入报告，以深入了解Taysha Gene Therapies Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

营业总收入

-100.00%0.00

171.27%5.49M

-100.00%0.00

78.60%1.99M

-32.51%2.30M

-43.90%2.02M

-62.33%1.79M

-53.57%1.11M

-27.52%3.41M

44.04%3.60M

--4.75M

--2.40M

--4.71M

--2.50M

--0.00

----

营业收入

-100.00%0.00

171.27%5.49M

-100.00%0.00

78.60%1.99M

-32.51%2.30M

-43.90%2.02M

-62.33%1.79M

-53.57%1.11M

-27.52%3.41M

44.04%3.60M

--4.75M

--2.40M

--4.71M

--2.50M

--0.00

----

营业费用

83.31%43.49M

53.89%33.78M

48.91%34.02M

28.24%28.74M

-14.48%23.72M

13.16%21.95M

12.11%22.85M

-13.06%22.41M

30.45%27.74M

-8.49%19.40M

-19.94%20.38M

-22.75%25.78M

-57.17%21.27M

-57.36%21.20M

-49.77%25.46M

-18.15%33.37M

54.72%49.65M

170.72%49.72M

236.95%50.68M

--40.77M

--32.09M

--18.37M

--15.04M

研发费用

117.21%33.81M

62.82%24.95M

72.25%25.75M

33.62%20.14M

-24.65%15.56M

20.84%15.32M

26.76%14.95M

-23.84%15.07M

65.07%20.66M

-8.51%12.68M

-29.71%11.79M

-15.80%19.79M

-67.23%12.51M

-63.44%13.86M

-57.56%16.77M

-23.29%23.51M

60.07%38.18M

209.28%37.92M

257.49%39.53M

--30.64M

--23.85M

--12.26M

--11.06M

折旧摊销及损耗

-1.67%295.00K

-1.32%300.00K

-4.67%286.00K

-6.83%300.00K

-7.69%300.00K

-24.00%304.00K

-9.37%300.00K

-19.50%322.00K

-1.81%325.00K

0.00%400.00K

10.33%331.00K

33.33%400.00K

10.33%331.00K

91.39%400.00K

80.72%300.00K

252.94%300.00K

837.50%300.00K

3383.33%209.00K

--166.00K

--85.00K

--32.00K

--6.00K

----

营业利润

-103.01%-43.49M

-41.98%-28.30M

-61.56%-34.02M

-25.61%-26.75M

11.96%-21.42M

-26.18%-19.93M

-34.71%-21.06M

8.92%-21.30M

-46.93%-24.33M

15.52%-15.80M

38.59%-15.63M

29.93%-23.38M

66.65%-16.56M

62.39%-18.70M

49.77%-25.46M

18.15%-33.37M

-54.72%-49.65M

-170.72%-49.72M

-236.95%-50.68M

---40.77M

---32.09M

---18.37M

---15.04M

净非营业利息收入（费用）

利息收入

95.02%2.59M

68.82%2.87M

50.40%3.17M

29.10%1.86M

-21.68%1.33M

-11.50%1.70M

89.99%2.11M

545.74%1.44M

430.72%1.69M

865.33%1.92M

12222.22%1.11M

725.93%223.00K

2178.57%319.00K

586.21%199.00K

-75.68%9.00K

-32.50%27.00K

-78.79%14.00K

-40.82%29.00K

--37.00K

--40.00K

--66.00K

--49.00K

----

利息费用

-52.63%9.00K

-45.45%12.00K

-37.50%15.00K

-37.04%17.00K

-34.48%19.00K

-96.91%22.00K

-98.37%24.00K

-98.13%27.00K

-97.89%29.00K

-10.43%713.00K

36.46%1.47M

93.81%1.44M

104.46%1.37M

15.20%796.00K

98.53%1.08M

282.99%743.00K

--672.00K

--691.00K

54200.00%543.00K

--194.00K

--0.00

--1.00K

特殊收入（费用）

-2.94%-1.47M

-411.61%-2.38M

71.76%-1.83M

-59.96%-1.73M

-2.73%-1.43M

-100.75%-465.00K

93.60%-6.47M

---1.08M

---1.39M

271.21%62.35M

---101.07M

----

---36.42M

--0.00

----

--0.00

其他非经营性收入（费用）

-338.46%-31.00K

54.55%-30.00K

54.32%-37.00K

-664.29%-237.00K

360.00%13.00K

-186.96%-66.00K

-326.32%-81.00K

1300.00%42.00K

37.50%-5.00K

-283.33%-23.00K

-1800.00%-19.00K

200.00%3.00K

0.00%-8.00K

---6.00K

---1.00K

---3.00K

---8.00K

----

税前利润

-96.99%-42.41M

-48.26%-27.85M

-28.24%-32.73M

-28.45%-26.88M

10.52%-21.53M

-139.35%-18.79M

78.20%-25.52M

14.92%-20.93M

-36.54%-24.06M

185.68%47.74M

-341.39%-117.09M

27.85%-24.60M

64.98%-17.62M

-10.59%-55.72M

48.18%-26.53M

16.70%-34.09M

-57.12%-50.32M

-175.06%-50.39M

-240.29%-51.19M

---40.93M

---32.02M

---18.32M

---15.04M

所得税

--0.00

----

--0.00

----

除税后利润

-96.99%-42.41M

-48.26%-27.85M

-28.24%-32.73M

-28.45%-26.88M

10.52%-21.53M

-139.35%-18.79M

78.20%-25.52M

14.92%-20.93M

-36.54%-24.06M

185.68%47.74M

-341.39%-117.09M

27.85%-24.60M

64.98%-17.62M

-10.59%-55.72M

48.18%-26.53M

16.70%-34.09M

-57.12%-50.32M

-175.06%-50.39M

-240.29%-51.19M

---40.93M

---32.02M

---18.32M

---15.04M

持续经营利润

-96.99%-42.41M

-48.26%-27.85M

-28.24%-32.73M

-28.45%-26.88M

10.52%-21.53M

-139.35%-18.79M

78.20%-25.52M

14.92%-20.93M

-36.54%-24.06M

185.68%47.74M

-341.39%-117.09M

27.85%-24.60M

64.98%-17.62M

-10.59%-55.72M

48.18%-26.53M

16.70%-34.09M

-57.12%-50.32M

-175.06%-50.39M

-240.29%-51.19M

---40.93M

---32.02M

---18.32M

---15.04M

归属于母公司的净利润

-96.99%-42.41M

-48.26%-27.85M

-28.24%-32.73M

-28.45%-26.88M

10.52%-21.53M

-139.35%-18.79M

78.20%-25.52M

14.92%-20.93M

-36.54%-24.06M

185.68%47.74M

-341.39%-117.09M

27.85%-24.60M

64.98%-17.62M

-10.59%-55.72M

48.18%-26.53M

16.70%-34.09M

-57.12%-50.32M

-175.06%-50.39M

-240.29%-51.19M

---40.93M

---32.02M

---18.32M

---15.04M

归属于普通股东的净利润

-96.99%-42.41M

-48.26%-27.85M

-28.24%-32.73M

-28.45%-26.88M

10.52%-21.53M

-139.35%-18.79M

78.20%-25.52M

14.92%-20.93M

-36.54%-24.06M

185.68%47.74M

-341.39%-117.09M

27.85%-24.60M

64.98%-17.62M

-10.59%-55.72M

48.18%-26.53M

16.70%-34.09M

-57.12%-50.32M

-175.06%-50.39M

-240.29%-51.19M

---40.93M

---32.02M

---18.32M

---15.04M

基本每股收益

-44.70%-0.12

-11.36%-0.08

2.78%-0.09

-0.36%-0.09

23.17%-0.08

-130.87%-0.07

89.77%-0.10

76.52%-0.09

62.65%-0.10

123.00%0.23

-43.75%-0.93

54.92%-0.38

78.87%-0.28

25.42%-0.99

51.89%-0.65

22.22%-0.85

-52.26%-1.32

-149.12%-1.32

-209.11%-1.35

---1.09

---0.87

---0.53

---0.44

稀释每股收益

-44.70%-0.12

-11.36%-0.08

2.78%-0.09

-0.36%-0.09

23.17%-0.08

-130.87%-0.07

89.77%-0.10

76.52%-0.09

62.65%-0.10

123.00%0.23

-43.75%-0.93

54.92%-0.38

78.87%-0.28

25.42%-0.99

51.89%-0.65

22.22%-0.85

-52.26%-1.32

-149.12%-1.32

-209.11%-1.35

---1.09

---0.87

---0.53

---0.44

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Taysha Gene Therapies Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 TSHA 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Taysha Gene Therapies Inc 财年末的营收是多少？



Taysha Gene Therapies Inc 2025 财年营收为 9.77M，高于上一财年的8.33M。

Taysha Gene Therapies Inc 全年的净利润是多少？



Taysha Gene Therapies Inc 2025 财年净利润为 -109.00M。

Taysha Gene Therapies Inc 上一季度的净利润是多少？



Taysha Gene Therapies Inc 最近一个季度的净利润为 -42.41M。

Taysha Gene Therapies Inc 年度营业利润是多少？



Taysha Gene Therapies Inc 2025 财年的营业利润为 -110.50M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。